0

The full content of Annals is available to subscribers

Subscribe/Learn More  >
Brief Communications |

Effects of Sodium Intake on Albumin Excretion in Patients with Diabetic Nephropathy Treated with Long-Acting Calcium Antagonists

George L. Bakris, MD; and Amy Smith, RN
[+] Article and Author Information

From Rush-Presbyterian-St. Luke's Medical Center, Chicago, Illinois. Acknowledgments: The authors thank Dr. Sue Leurgans for technical help with statistical analyses. Grant Support: By an unrestricted investigator-initiated grant from Hoechst Marion Roussell. Requests for Reprints: George Bakris, MD, Rush-Presbyterian-St. Luke's Medical Center, Rush Hypertension Center, Suite 117, 1725 West Harrison Street, Chicago, IL 60612. Current Author Addresses: Dr. Bakris and Ms. Smith: Rush-Presbyterian-St. Luke's Medical Center, Rush Hypertension Center, Suite 117, 1725 West Harrison Street, Chicago, IL 60612.


Copyright ©2004 by the American College of Physicians


Ann Intern Med. 1996;125(3):201-204. doi:10.7326/0003-4819-125-3-199608010-00007
Text Size: A A A

Objective: To determine whether sodium intake alters albumin excretion in patients with nephropathy from non–insulin-dependent diabetes mellitus who were treated with two different long-acting calcium antagonists.

Design: Prospective, crossover, open-label trial.

Setting: Rush-Presbyterian-St. Luke's Medical Center.

Patients: 9 men and 6 women (mean age ±SD, 56 ± 8 years) with non–insulin-dependent diabetes mellitus, hypertension, renal insufficiency, and macroalbuminuria.

Intervention: Diltiazem (mean dose, 392 ± 27 mg/d) or nifedipine (mean dose, 83 ± 9 mg/d) was used to decrease blood pressure to less than 140/90 mm Hg. All patients also received furosemide concomitantly for blood pressure control.

Results: Blood pressure reduction with once-daily diltiazem decreased urine albumin excretion (2967 ± 784 mg/d at baseline compared with 1294 ± 679 mg/d after diltiazem therapy; P < 0.05) at 4 weeks while patients received a diet consisting of 50 mEq of sodium per day. Albumin excretion did not decrease when sodium intake was increased to 250 mEq/d, and blood pressure was reduced to levels similar to those seen with the low-sodium diet. Similar blood pressure reduction with once-daily nifedipine did not significantly alter albumin excretion regardless of sodium intake.

Conclusion: Sodium intake affects the albumin-decreasing effects of certain calcium antagonists. Recent studies suggest that antihypertensive medications that reduce albumin excretion and arterial pressure correlate with reduced renal mortality compared with medications that do not have albumin-decreasing effects. Thus, a low-sodium diet should be prescribed to maximize the albumin-decreasing effects of certain calcium antagonists.

Figures

Grahic Jump Location
Figure 1. Asterisks indicate weeks during which blood pressure, creatinine clearance, albumin excretion, and sodium excretion (2 consecutive days) were measured. For weeks marked with daggers, only blood pressure was measured.
Study protocol.
Grahic Jump Location

Tables

References

Letters

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Comments

Submit a Comment
Submit a Comment

Summary for Patients

Clinical Slide Sets

Terms of Use

The In the Clinic® slide sets are owned and copyrighted by the American College of Physicians (ACP). All text, graphics, trademarks, and other intellectual property incorporated into the slide sets remain the sole and exclusive property of the ACP. The slide sets may be used only by the person who downloads or purchases them and only for the purpose of presenting them during not-for-profit educational activities. Users may incorporate the entire slide set or selected individual slides into their own teaching presentations but may not alter the content of the slides in any way or remove the ACP copyright notice. Users may make print copies for use as hand-outs for the audience the user is personally addressing but may not otherwise reproduce or distribute the slides by any means or media, including but not limited to sending them as e-mail attachments, posting them on Internet or Intranet sites, publishing them in meeting proceedings, or making them available for sale or distribution in any unauthorized form, without the express written permission of the ACP. Unauthorized use of the In the Clinic slide sets will constitute copyright infringement.

Toolkit

Buy Now

to gain full access to the content and tools.

Want to Subscribe?

Learn more about subscription options

Advertisement
Related Articles
Topic Collections
Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.
(Required)
(Required)